Regulus Therapeutics Inc (NASDAQ:RGLS)

12.85
Delayed Data
As of May 22
 +0.10 / +0.78%
Today’s Change
6.08
Today|||52-Week Range
25.60
-19.89%
Year-to-Date

Stock Price Forecast

The 5 analysts offering 12-month price forecasts for Regulus Therapeutics Inc have a median target of 30.00, with a high estimate of 41.00 and a low estimate of 25.00. The median estimate represents a +133.46% increase from the last price of 12.85.

Analyst Recommendations

The current consensus among 6 polled investment analysts is to Buy stock in Regulus Therapeutics Inc. This rating has held steady since May, when it was unchanged from a Buy rating.Move your mouse over past
months for detail

 
 
 
 
 
 
 
 

Earnings and Sales Forecasts

Current Quarter

Earnings per Share
-$0.29
Sales
$2.3M
Reporting Date
Aug 05

Earnings per Share

Move your mouse over a quarter or year to see how estimates have changed over time.

Growthquarterly 0.69%
 
 
 
 
 
 
Growthannually 15.64%
 
 
 
 
 

Sales

Growthquarterly -45.77%
 
 
 
 
 
 
Growthannually 120.52%
 
 
 
 
 
Key to the earnings and sales forecast charts.

To view my watchlist

Not a member yet?

Sign up now for a free account